ANCA-associated vasculitis in scleroderma: A case series of fourteen patients

Rheumatology Reports

Volumn 3, Issue 1, 2011, Pages 3-8

  Liang, Kimberly P ^a   Michet, Clement J ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Antibodies; Antineutrophil cytoplasmic; Scleroderma; Vasculitis

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYELOPEROXIDASE; PREDNISONE; PREGABALIN; RHEUMATOID FACTOR;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE EXACERBATION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DYSPHAGIA; FEMALE; GASTROESOPHAGEAL REFLUX; HEART CATHETERIZATION; HOSPITAL READMISSION; HUMAN; HYPERSENSITIVITY; LABORATORY TEST; LEUKOPENIA; LIVER FUNCTION TEST; LUNG EXAMINATION; MALE; MOUTH ULCER; NEUROPATHIC PAIN; OXYGEN THERAPY; PERIPHERAL NEUROPATHY; PHOTOSENSITIVITY; PHYSICAL EXAMINATION; PNEUMONIA; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; REVIEW; SCLERODERMA; SKIN BIOPSY; TELANGIECTASIA; XEROSTOMIA;

EID: 79953155289     PISSN: 20367511     EISSN: 2036752X     Source Type: Journal    
DOI: 10.4081/rr.2011.e2     Document Type: Review

References (35)

1. Wutzl AL, Foley RN, O'Driscoll BR, et al. Microscopic polyangiitis presenting as pulmonary-renal syndrome in a patient with long-standing diffuse cutaneous systemic sclerosis and antibodies to myeloperoxidase. Arthritis Rheum 2001; 45:533-6.
2. Oddis CV, Eisenbeis CH, Jr., Reidbord HE, et al. Vasculitis in systemic sclerosis: association with Sjogren's syndrome and the CREST syndrome variant. J Rheumatol 1987; 14: 942-8.
3. Kamen DL, Wigley FM, Brown AN. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma--a different kind of renal crisis. J Rheumatol 2006;33:1886-8.
4. Endo H, Hosono T, Kondo H. Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 1994;21: 864-70.
5. Kiraz S, Simsek H, Ertenli I, et al. Antineutrophil cytoplasmic antibodies in systemic sclerosis. Clin Rheumatol 1996; 15: 519-20.
6. Herrera-Esparza R, Aguilar JL, Saucedo A, et al. Scleroderma with type III glomeru-lonephritis and MPO-ANCA antibodies in the serum. J Eur Acad Dermatol Venereol 2005; 19: 617-20.
7. Carvajal I, Bernis C, Sanz P, et al. Antineutrophil cytoplasmic autoantibodies (ANCA) and systemic sclerosis. Nephrol Dial Transplant 1997; 12: 576-7.
8. Omote A, Muramatsu M, Sugimoto Y, et al. Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies--related scleroderma renal crisis treated with double-filtration plasmapheresis. Intern Med 1997; 36: 508-13.
9. Cheung G, Chew G, Wyndham R, et al. Myeloperoxidase-antineutrophil cytoplasmic antibody seroconversion and fulminant vasculitis in Scl-70-positive scleroderma. Intern Med J 2007; 37: 205-7.
10. Locke IC, Worrall JG, Leaker B, et al. Autoantibodies to myeloperoxidase in systemic sclerosis. J Rheumatol 1997; 24: 86-9.
11. Ruffatti A, Sinico RA, Radice A, et al. Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis. J Rheumatol 2002; 29: 918-23.
12. Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum 1998; 41: 1521-37.
13. Akimoto S, Ishikawa O, Tamura T, Miyachi Y. Antineutrophil cytoplasmic autoantibodies in patients with systemic sclerosis. Br J Dermatol 1996; 134: 407-10.
14. Hillis GS, Khan IH, Simpson JG, Rees AJ. Scleroderma, D-penicillamine treatment, and progressive renal failure associated with positive antimyeloperoxidase antineutrophil cytoplasmic antibodies. Am J Kidney Dis 1997; 30: 279-81.
15. Villaverde V, Balsa A, Cabezas JA, et al. Normotensive renal failure in a patient with systemic sclerosis and p-antineutrophil cytoplasmic autoantibodies which developed into Paget's disease of bone after immunosuppressive therapy. Rheumatology (Oxford) 1999; 38: 190-1.
16. Katrib A, Sturgess A, Bertouch JV. Systemic sclerosis and antineutrophil cytoplasmic autoantibody-associated renal failure. Rheumatol Int 1999; 19: 61-3.
17. Casari S, Haeney M, Farrand S, Herrick A. Antineutrophil cytoplasmic antibodies a "Red Flag" in patients with systemic sclerosis. J Rheumatol 2002; 29: 2666-7.
18. Tomioka M, Hinoshita F, Miyauchi N, et al. ANCA-related crescentic glomerulonephritis in a patient with scleroderma without marked dermatological change and malignant hypertension. Intern Med 2004; 43: 496-502.
19. Rho YH, Choi SJ, Lee YH, et al. Scleroderma associated with ANCA-associated vasculitis. Rheumatol Int 2006; 26: 465-8.
20. Anders HJ, Wiebecke B, Haedecke C, et al. MPO-ANCA-Positive crescentic glomeru-lonephritis: a distinct entity of scleroderma renal disease? Am J Kidney Dis 1999; 33: e3.
21. Arnaud L, Huart A, Plaisier E, et al. ANCA-related crescentic glomerulonephritis in systemic sclerosis: revisiting the "nor-motensive scleroderma renal crisis". Clin Nephrol 2007; 68: 165-70.
22. Harashima S, Yoshizawa S, Horiuchi T, et al. [A case of systemic sclerosis with crescentic glomerulonephritis associated with perinuclear-antineutrophil cytoplasmic antibody (p-ANCA)]. Nihon Rinsho Meneki Gakkai Kaishi 1999; 22: 86-92.
23. Kobayashi M, Saito M, Minoshima S, et al. [A case of progressive systemic sclerosis with crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) and anti-glomerular basement membrane antibody (anti-GBM Ab)]. Nippon Jinzo Gakkai Shi 1995; 37: 207-11.
24. Martinez Ara J, Picazo ML, Torre A, et al. [Progressive systemic sclerosis associated with anti-myeloperoxidase ANCA vasculitis with renal and cutaneous involvement]. Nefrologia 2000; 20: 383-6.
25. Mizutani A, Tanaka I, Katayama M, et al. [A case of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) related glomerulonephritis associated with systemic sclerosis treated by steroid pulse therapy: a case report]. Ryumachi 2000; 40: 828-32.
26. Maes B, Van Mieghem A, Messiaen T, et al. Limited cutaneous systemic sclerosis associated with MPO-ANCA positive renal small vessel vasculitis of the microscopic polyangiitis type. Am J Kidney Dis 2000; 36: E16.
27. Gaskin G, Thompson EM, Pusey CD. Goodpasture-like syndrome associated with anti-myeloperoxidase antibodies following penicillamine treatment. Nephrol Dial Transplant 1995; 10: 1925-8.
28. Vazquez-Del Mercado M, Mendoza-Topete A, Best-Aguilera CR, Garcia-De La Torre I. Diffuse alveolar hemorrhage in limited cutaneous systemic sclerosis with positive perinuclear antineutrophil cytoplasmic antibodies. J Rheumatol 1996; 23: 1821-3.
29. Foulon G, Delaval P, Valeyre D, et al. ANCA-associated lung fibrosis: analysis of 17 patients. Respir Med 2008; 102: 1392-8.
30. Tzelepis GE, Kokosi M, Tzioufas A, et al. Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J 2010; 36: 116-21.
31. Helfrich DJ, Banner B, Steen VD, Medsger TA, Jr. Normotensive renal failure in systemic sclerosis. Arthritis Rheum 1989; 32: 1128-34.
32. Herrick AL, Oogarah PK, Freemont AJ, et al. Vasculitis in patients with systemic sclerosis and severe digital ischaemia requiring amputation. Ann Rheum Dis 1994; 53: 323-6.
33. Caramaschi P, Biasi D, Tonolli E, et al. Antineutrophil cytoplasmic antibodies in scleroderma patients: first report of a case with anti-proteinase 3 antibodies and review of the literature. Joint Bone Spine 2002; 69: 177-80.
34. Huong DL, Papo T, Gatfosse M, et al. Antineutrophil cytoplasmic autoantibodies in systemic sclerosis with renal failure. J Rheumatol 1995; 22: 791-2.
35. Ramos-Casals M, Nardi N, Brito-Zeron P, et al. Atypical autoantibodies in patients with primary Sjogren syndrome: clinical characteristics and follow-up of 82 cases. Semin Arthritis Rheum 2006; 35: 312-21.